AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimfirst-MP1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Zyphar's Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimfirst-MP1 Tablet SR

Glimepiride and Metformin extended-release tablets offer combined blood glucose regulation. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume your regular schedule. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals must consult their doctor. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption to minimize potential side effects.

Uses of Glimfirst-MP1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimfirst-MP1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimfirst-MP1 Tablet SR should be administered with a meal.

Common Side effects of Glimfirst-MP1 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimfirst-MP1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimfirst-MP1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be administered with a meal.

How Glimfirst-MP1 Tablet SR works:

Glimfirst-MP1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimfirst-MP1 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimfirst-MP1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimfirst-MP1 tablets pose a likely risk during lactation. Preliminary human evidence indicates potential transfer to breast milk, potentially harming the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimfirst-MP1 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimfirst-MP1 Tablet SR is contraindicated in patients exhibiting severe renal dysfunction. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfirst-MP1 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimfirst-MP1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimfirst-MP1 Tablet SR :

Should you forget a dose of Glimfirst-MP1 Tablet SR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication schedule. Avoid taking a double dose.

Facts to Know About Glimfirst-MP1 Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimfirst-MP1 Tablet SR

Drinking alcohol while taking Glimfirst-MP1 Tablet SR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Tell your doctor before taking Glimfirst-MP1 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform them if you are pregnant, breastfeeding, or premenopausal, and about all medications you're taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Glimfirst-MP1 Tablet SR, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Glimfirst-MP1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimfirst-MP1 Tablet SR
66
MRP 77
13% off